So according to your analysis, MindMed in 2020, and the "rookie" MF at Revive, along with the "rookie" management teams at Mydecine, MindCure Psyched, Cybin, Numinus and Field Trip all made the same ""terrible"" decision simultaneously???
Have you actually looked at the other deals? They're all basically the same, the only difference is how much the shares were discounted.
This seems to be accounted for in part by how large the initial share purchase was, ie, the larger the buy, the "bigger" the discount.
The Warrants are all approximately 140%-150% of the share buy price.
Glad to know we have such talented posters here to warn us about the managerial malpractice at Revive.
WOW!!!
Market Data 
Markets 
